The spinal cord is unable to regenerate after injury largely due to growth-inhibition by an inflammatory response to the injury that fails to resolve, resulting in secondary damage and cell death. An approach that prevents inhibition by attenuating the inflammatory response and promoting its resolution through the transition of macrophages to anti-inflammatory phenotypes is essential for the creation of a growth permissive microenvironment. Viral gene delivery to induce the expression of anti-inflammatory factors provides the potential to provide localized delivery to alter the host inflammatory response. Initially, we investigated the effect of the biomaterial and viral components of the delivery system to influence the extent of cell infiltration and the phenotype of these cells. Bridge implantation reduces antigen-presenting cell infiltration at day 7, and lentivirus addition to the bridge induces a transient increase in neutrophils in the spinal cord at day 7 and macrophages at day 14.
| I N T R O D U C T I O N
To date, the only treatment for treating spinal cord injury (SCI) with any degree of success in clinical trials is methylprednisolone, which mitigates the inflammatory response after injury. 1 Inflammation after SCI initiates a damaging secondary injury response that establishes multiple barriers (e.g., accumulation of myelin debris, and reactive gliosis) to regeneration and restoration of function. The inflammatory cascade begins with upregulated production of inflammatory cytokines, chemokines, and reactive oxygen species (ROS), [2] [3] [4] [5] which leads to recruitment of peripheral immune cells 6 and activation of local microglia, oligodendrocytes, and astrocytes. [7] [8] [9] [10] Early recruitment of neutrophils (PMNs)-and later macrophages-comprises the innate immune response to SCI.
PMNs and macrophages recruited to the injury can remove pathogens; however, they also propagate secondary injury, which results in death of neurons and oligodendrocytes. 11, 12 Macrophages, in particular, also phagocytose debris left behind by necrotic or apoptotic cells, including inhibitory myelin debris whose slow clearance contributes to the inability of axons to regenerate. 13, 14 In addition, inflammatory cytokines produced by PMNs and macrophages induce astrocytes to adopt a reactive state in which they proliferate and can increase the secretion of chondroitin sulfate proteoglycans (CSPGs). These reactive astrocytes then form an inhibitory glial scar that surrounds the injury site and prevents regenerating axons from crossing. 9, [14] [15] [16] [17] [18] [19] In normal wound healing, the inflammatory response resolves over time, leaving behind regenerated, functional tissue. In contrast, SCI results in a chronic immune response characterized by the persistence of inflammatory cells, insufficient clearance of cellular debris at the injury, and formation of a robust glial scar that creates a barrier that limits regeneration. 12, 20, 21 In peripheral tissues, a transition in macrophage phenotype from inflammatory (M1 or classically activated) to antiinflammatory (M2 or alternatively activated) is largely responsible for dampening and resolving the immune response after injury. [22] [23] [24] However, this transition does not occur on a sufficient scale after SCI. Instead, M1 macrophages chronically persist in zones of axon degeneration, where they propagate inflammation and inhibit axon regeneration. [25] [26] [27] [28] [29] [30] Though a preponderance of evidence has shown that M1 macrophages predominate within the injury site after SCI, M2 macrophages are present-typically peaking at day 14 after injury in rodents. 31 M2 macrophages generally have enhanced phagocytic capabilities 32, 33 and can promote axon growth across inhibitory boundaries in vitro. 25 They stimulate tissue repair through attenuated production of inflammatory cytokines, reduced ROS production, and expression of pro-resolving cytokines such as IL-
10
. 34 In contrast, M1 macrophages are characterized by increased production of pro-inflammatory cytokines, ROS and NO-each of which leads to neuron and oligodendrocyte toxicity. 25, 35 Several factors promote M2
phenotypes including IL-4, IL-13, glucocorticoids, and IL-10. Of these, IL-10 was selected for this study due to its ability to promote neuron survival while reducing leukocyte infiltration and activation. [36] [37] [38] Macrophage depletion has been investigated as a potential solution to mitigate the inflammatory response, but there have been mixed results.
Treatment with liposome-encapsulated clodronate to deplete hematogenous macrophages improved partial hindlimb recovery and tissue repair in one study 39 and decreased fibrotic scarring while increasing axon numbers in a second study. 40 In contrast, antibody-mediated depletion of CD11c 1 monocytes/macrophages or conditional ablation by diphtheria toxin each reduced functional recovery. 41 These seemingly contradictory results suggest that specific macrophages phenotypes may have different effects on tissue repair and that eliminating or enhancing specific subtypes may be more beneficial than targeting the entire macrophage population.
Additionally, there may be unintended systemic or local consequences of depleting the entire population, such as increased susceptibility to infection and disease and reduced clearance of inhibitory debris.
While macrophage phenotype has often been depicted as a binary system where a cell is either M1 or M2 at any given time, it is now thought that macrophages exist along a continuous spectrum of activa- 43, 44 Despite observations of these macrophage subtypes in vitro, it remains unclear how this correlates with macrophage activation in vivo. Macrophages retain inherent capacity for plasticity along this activation spectrum, dynamically responding to changes in their local environment. 36, 45 This dynamic plasticity makes macrophages a compelling target for resolving inflammation in the spinal cord to enable regeneration.
In addition to addressing neuroinflammation, therapies for spinal cord regeneration must provide physical support and guidance for regenerating axons across the injury site. SCI therapies focused solely on resolution of neuroinflammation have largely failed due to both lack of a growth-promoting substrate and accumulation of inhibitory factors at the injury. 46, 47 While immunomodulatory strategies can reduce inflammation and promote axonal sparing, guidance of regenerating axons requires a permissive substrate. Initial attempts to provide a permissive bridge across spinal cord lesions implanted donor peripheral nerve grafts. 48 More recently, synthetic multiple-channel bridges have been developed to replicate the synergistic advantages of peripheral nerve grafts-physical support and guidance and a biologically active, pro-regenerative microenvironment. [49] [50] [51] [52] [53] [54] We have previously demonstrated that multiple-channel bridges made from biodegradable poly (lactide-co-glycolide (PLG) support robust crossing of axons across the lesion site, resulting in formation of regenerated axon bundles after complete bridge degradation 6 months after SCI. 54, 55 Longitudinal, macroscale channels within these bridges act as conduits for axons regenerating across the injury site, while scaffold microporosity supports host cell infiltration and tissue integration. 55, 56 Herein, we investigate the hypothesis that localized lentiviral expression of IL-10 from multiple-channel PLG bridges will modulate the numbers, phenotypes, and proportions of leukocyte populations infiltrating the bridge to promote a "resolving" anti-inflammatory environment thought to be more permissive to regeneration. In addition to providing a substrate for regeneration, PLG bridges have also served as View, CA, USA) and then concentrated using Vivaspin centrifugal concentrators (Sartorius, G€ ottingen, Germany). Viral titers used throughout the study were 2E10 IU/ml as determined by the Lentivirus qPCR Titer Kit (Applied Biological Materials, Richmond, BC, Canada).
| Fabrication of multiple-channel bridges
Bridges were fabricated using a sacrificial template variation 61 of the gas foaming/particulate leaching technique, 54 as previously described. 62 Briefly, PLG (75:25 lactide:glycolide; inherent viscosity 0.76 dl/g; Lake-
shore Biomaterials, Birmingham, AL, USA) was dissolved in dichloromethane (6% w/w) and emulsified in 1% poly(vinyl alcohol) using a homogenizer (PolyTron 3100; Kinematica AG, Littau, Switzerland) at 3000 rpm to create microspheres (z-average diameter 1mm). D-sucrose was caramelized, cooled, and drawn from solution with a Pasteur pipette to make sugar fibers. These fibers were coated with a mixture of PLG microspheres and salt (63-106 lm) and pressed into a salt-lined aluminum mold. The materials were then equilibrated with CO 2 gas (800 psi) for 16
hrs and then gas foamed in a custom-made pressure vessel. Bridges were subsequently cut into 2.25 mm sections and leached for 2 hrs to remove porogens. The bridges are dried overnight and stored in a desiccator. 
| Heparinization of nerve bridges

| Tissue processing and immunofluorescence
Spinal cord tissue was collected at days 7, 14, and 28, which were chosen to represent acute, subacute and intermediate phases of regeneration respectively. It may be noted that days 7 and 14 are at the tail end of their respective phases; however, it is not possible to extract the spinal cord and bridge together prior to day 7 as the bridge falls out due to a weak interface tissue-bridge interface. Additionally, cellular infiltration is lower at earlier time points, making flow cytometry challenging. Cell counts were then normalized to counted area in each tissue section.
Macrophage shape was characterized for each positive cell and cells were binned as fibrous/elongated, round and not ruffled with a bright F4/80 1 perimeter, or as multinucleated foreign body giant cell (FBGC).
To assess the numbers of regenerated and myelinated axons, NF200
was used to identify axons, NF200 in MOPS buffer, as previously described by Beck et al. 20 Cells were subsequently blocked with a solution containing 1% normal mouse and rat serum (Sigma Aldrich) and anti-mouse CD16/32 (eBioscience) and stained for viability using fixable violet dead cell stain (Invitrogen) and stained with the specific antibodies listed above. Data were acquired on a BD LSR II cytometer, and analyzed using FloJo software. Fluorescence minus one staining was used as a negative control.
The following flow cytometry antibodies were used: v500-conjugated 30-F11 against CD45, PE(phycoerythrin)/Cy7-conjugated 
| IL-10 gene delivery from bridges reduces PMN infiltration
The immune response to bridges with and without delivery of IL-10-encoding lentivirus was investigated to determine if the infiltration of inflammatory cells can be modulated through localized cytokine expression. In previous reports, we have demonstrated lentiviral IL-10 expression 36 and sustained transgene expression for at least 8 weeks in the injured spinal cord. 63 The flow cytometry studies were performed at however, by day 28, the macrophage percentage increased in the bridge conditions such that they were no longer significantly less than the no bridge condition ( Figure 3B ). Notably, these changes represent the percentage of CD45 1 cells that were also F4/80 1 ; thus, the increase in macrophage percentage at day 28 does not imply an increase in the total number of macrophages. Finally, delivery of IL-10-encoding lentivirus reduced numbers of infiltrating PMNs by 3.5-fold when compared to the bridges loaded with control lentivirus at Day 7 (p < .05) ( Figure 3C ).
Bridges loaded with IL-10-encoding lentivirus had similar numbers of infiltrating PMNs as in hemisections with no bridge implant. Localized IL-10 expression at the bridge did sustain a 3.5-fold reduction of PMN infiltration through day 28 (relative to the no bridge control) (p < .05) ( Figure   3C ). Additionally, IL-10 expression reduced the mean level of PMN infiltration by 2.4-fold compared to all other bridges, though this decrease was not statistically significant ( Figure 3C ).
| IL-10 gene delivery from bridges increases M2 macrophage infiltration
Immunofluorescence staining of tissue sections was applied to investi- 
| Axon regeneration and myelination
Axon numbers and myelination were quantified at day 28 to assess whether IL-10 overexpression would prove detrimental, which has been reported in the peripheral nervous system. 71 Myelinated (NF200 Figure 7E ).
| Motor function is improved with IL-10
Motor function in the ipsilateral hindlimb was characterized over the first 28 days after SCI using the BMS ( of HSV-encoding IL-10 improved axonal sparing and functional recovery. 37, 38 Despite several studies investigating IL-10 delivery for SCI, the effects of sustained localized delivery on dampening and resolving the immune response to promote regeneration have not previously been studied. 59 and are the focus of the studies herein.
We initially demonstrate that delivery of IL-10-encoding lentivirus can decrease PMN infiltration into biomaterial bridges implanted following SCI, and that though the loading of lentivirus to bridges may promote PMN infiltration, IL-10 over-expression reverses this effect.
Although PMNs are transient participants in the immune response following injury to peripheral tissues, they can persist for weeks after injury to the spinal cord. 12, 20 Furthermore, though virus delivery from biomaterials can be used to enhance nerve regeneration, 54, 76 addition of virus to the biomaterial platform can increase the extent of cell infiltration. [77] [78] [79] Secretion of chemokines from the increased immune cells may be responsible for the increase in PMN infiltration at day 7 and 28 reported here ( Figure 3C ), though increased cytokines would also be expected to simultaneously influence macrophage infiltration, which was not observed and is in agreement with a previous report. 58 Due to their primarily bactericidal role in wound healing, PMNs are not expected to provide neuroprotection and are primarily detrimental in SCI. 12 PMNs (and macrophages) release cytokines, free radicals, eicosanoids, and proteases, which are toxic to neurons and glia. In particular, superoxide, nitric oxide, and peroxynitrite are highly toxic and create irreversible damage to cellular components, inducing apoptosis. 80 The BMS was used to test for differences in motor function in the hindlimb ipsilateral to SCI (n 5 15 per group). Statistical analysis was completed using a two-way ANOVA with repeated measures and a Sid ak correction for multiple comparisons. Significant differences notated with *** (p < .001) or **** (p < .0001) Figure 4 , which may depend on the specific subtype and phase of regeneration (inflammatory, proliferative, or remodeling). 44 41 The exogenous monocytes differentiated into macrophages with an activated morphology, which was manifested by a large cell body with few to no processes, arginase expression, and IL-10 release. These factors suggested an anti-inflammatory phenotype, and the monocytes contributed to regeneration. 41 A subset of infiltrating monocyte-derived, anti-inflammatory macrophages may be essential for recovery, though these cells represent a specific subset of M2 macrophages and will require further characterization. 38 and indirectly by limiting the immune response. 59 Additionally, in our past work, differences in numbers of regenerating axons between conditions become more pronounced at later time points. 54 Thus, improved motor function observed in the current study suggests improved sparing and plasticity instead of regeneration. While these data suggest that IL-10 overexpression from PLG bridges effectively improves function after SCI, delivery of IL-10 in combination with neurotrophic factors known to promote axon regeneration, such as neurotrophin-3 (NT-3), 54, 57 may act synergistically to further improve both sparing and regeneration.
The present study indicates that immobilization of IL-10 lentivirus onto multiple channel bridges alters the immune response to create a microenvironment that is permissive to regeneration and shows promise as a translatable strategy. The bridges used are made of PLG, a biomaterial that has been utilized for decades in FDA-approved applications, including biodegradable sutures and drug delivery vehicles. 95 PLG is easily sterilized for clinical using standard techniques, most commonly g-irradiation. 96 Though safety has been cited as a concern for lentiviral vectors, there are ongoing clinical trials using lentivirus without adverse effects or evidence of insertional mutagenesis. [97] [98] [99] Pyrogens from virus production can be limited by purification through gravity-flow columns to yield endotoxin-free, concentrated plasmid, as done in these studies. Furthermore, good manufacturing practices (GMP) have been developed for large-scale preparation of lentivirus for clinical use. 98, 100 Finally, the hemisection model of SCI, while not perfectly representative of all SCI, is a translatable platform for studying the injury site and developing treatments. While contusive injuries represent the majority of SCI in the developed world, at least 28% of cases in the US military are penetrating, 101 and in South Africa, more than 60% of SCI is categorized as penetrating. 102 Moreover, the initial deficits resulting from penetrating SCI exhibit substantially less improvement over time than those from contusive injuries. 103 LITERATURE CITED
